rxstat › Drug prices › Remdesivir
Remdesivir (Veklury) price in Canada
No current shortage
Remdesivir 100 mg/vial powder for solution costs about $660.53 per billed unit (often a pen or vial) on public drug plan price lists across 2 provinces, before the pharmacy's dispensing fee.
Remdesivir has no current shortage reported in Canada. No active reports are on file.
Price by province
| Strength and form | AB | SK | ON |
|---|---|---|---|
| 100 mg/vial Powder For Solution | $660.53/unitnot covered | $660.53/unit | $660.53/unit |
| Plan coverage | Not covered | Special approval | Covered |
What you'll pay at the pharmacy
These are the prices public drug plans list for the drug itself. At the counter, pharmacies add a dispensing fee and in some provinces a markup, so paying cash costs more, and for cheap generics the fee is often more than the drug. If you have a public or private plan, your share depends on its deductible and co-pay.
Listed products by province
Alberta: 1 product
- Veklury 100 mg/vial Powder For Solution · GIL
Saskatchewan: 1 product
- Veklury 100 mg/vial Powder For Solution · GSI
Ontario: 1 product
- Veklury 100 mg/vial Powder For Solution · Gilead Sciences Canada, Inc.
Shortage status
No shortage or discontinuation reports have been filed with Health Canada for Remdesivir. rxstat watches those reports through the day; sign up below to hear if that changes.
Common questions
How much does Remdesivir cost in Canada?
Remdesivir 100 mg/vial powder for solution costs about $660.53 per billed unit (often a pen or vial) on public drug plan price lists across 2 provinces, before the pharmacy's dispensing fee.
Is Remdesivir covered by provincial drug plans?
On the public plans' own lists: Alberta: not covered; Saskatchewan: special approval; Ontario: covered. "Special approval" means the plan covers it only for some patients, on a request from the prescriber. "Price list" means the province publishes its price but not its coverage.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Related drugs (direct acting antivirals)
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.